Impact Factor:5.6

DOI number:10.3389/fphar.2020.00044

Journal:FRONTIERS IN PHARMACOLOGY

Co-author:Yin, WJ (Yin, Wen-jun), LY (Zhou, Ling-yun), Li, DY (Li, Dai-yang), Xie, YL (Xie, Yue-liang), Wang, JL (Wang, Jiang-lin), Zuo, SR (Zuo, Shan-ru), Liu, K (Liu, Kun), Hu, C (Hu, Can), Zhou, G (Zhou, Ge), Chen, LH (Chen, Lin-hua), Yang, HQ (Yang, Hui-qing)

Translation or Not:no

Pre One:Risk of non-melanoma skin cancer for rheumatoid arthritis patients receiving TNF antagonist: a systematic review and meta-analysis Next One:Validation of pre-operative risk scores of contrast-induced acute kidney injury in a Chinese cohort